PURE Bioscience (OTCMKTS:PURE) Posts Quarterly Earnings Results

PURE Bioscience (OTCMKTS:PURE) issued its quarterly earnings results on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports.

PURE Bioscience Trading Up 11.1 %

OTCMKTS PURE traded up $0.01 on Monday, hitting $0.07. 52,600 shares of the company’s stock were exchanged, compared to its average volume of 29,677. PURE Bioscience has a 52 week low of $0.06 and a 52 week high of $0.16. The stock has a 50-day moving average of $0.09 and a 200-day moving average of $0.08. The stock has a market cap of $7.83 million, a price-to-earnings ratio of -1.75 and a beta of 0.01.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.